Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 97.91% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 97.91% | -- | -- | -- | |
| Cost of Revenue | 101.37% | -- | -- | -- | |
| Gross Profit | 95.05% | -- | -- | -- | |
| SG&A Expenses | 85.32% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 80.64% | -- | -- | -- | |
| Operating Income | -62.89% | -- | -- | -- | |
| Income Before Tax | -34.77% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -34.77% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -34.77% | -- | -- | -- | |
| EBIT | -62.89% | -- | -- | -- | |
| EBITDA | -64.91% | -- | -- | -- | |
| EPS Basic | 39.72% | -- | -- | -- | |
| Normalized Basic EPS | 39.72% | -- | -- | -- | |
| EPS Diluted | 39.72% | -- | -- | -- | |
| Normalized Diluted EPS | 39.72% | -- | -- | -- | |
| Average Basic Shares Outstanding | 274.87% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 274.87% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |